Horan Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$350K Hold
901
0.12% 103
2025
Q1
$392K Hold
901
0.15% 86
2024
Q4
$332K Hold
901
0.13% 88
2024
Q3
$469K Hold
901
0.18% 66
2024
Q2
$488K Hold
901
0.21% 51
2024
Q1
$467K Hold
901
0.22% 47
2023
Q4
$425K Hold
901
0.21% 49
2023
Q3
$392K Hold
901
0.21% 54
2023
Q2
$400K Hold
901
0.17% 65
2023
Q1
$414K Hold
901
0.21% 49
2022
Q4
$462K Hold
901
0.26% 37
2022
Q3
$409K Hold
901
0.25% 39
2022
Q2
$434K Hold
901
0.26% 38
2022
Q1
$443K Hold
901
0.26% 31
2021
Q4
$418K Buy
+901
New +$379K 0.25% 33
2021
Q2
$344K Hold
901
0.24% 32
2021
Q1
$323K Hold
901
0.27% 26
2020
Q4
$289K Buy
901
+120
+15% +$36.8K 0.24% 36
2020
Q3
$210K Hold
781
0.21% 40
2020
Q2
$205K Hold
781
0.23% 29
2020
Q1
$177K Hold
781
0.24% 34
2019
Q4
$236K Buy
+781
New +$215K 0.26% 31

Other funds holding ELV

Horan Securities's ELV Position: Q2 2025 in Review

Horan Securities held its Elevance Health (ELV) position steady in Q2 2025 at 901 shares worth $350K. The position accounts for 0.12% of the portfolio, ranked #103.

Horan Securities first reported a position in ELV in Q4 2019 and has held it in 22 quarters since. The position peaked at $488K in Q2 2024. 1,593 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Horan Securities held 901 shares of Elevance Health worth $350K as of Q2 2025.
  • Horan Securities left its Elevance Health share count unchanged in Q2 2025.
  • Elevance Health made up 0.12% of Horan Securities's portfolio in Q2 2025, its #103 holding.
  • Horan Securities first reported a position in Elevance Health in Q4 2019 and has held it in 22 quarters since.
  • Horan Securities's Elevance Health position peaked at $488K in Q2 2024.
  • 1,593 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Horan Securities's 13F filing for Q2 2025, filed 6 Aug 2025.